PYYX PYXUS INTERNATIONAL, INC.

MIXED Impact: 6/10 8-K
Horizon weeks Filed Jun 4, 2026 Processed 8d 22h ago SEC 0000939930-26-000018
8-K Item 2.02: Earnings release
Latest settled — T+1d
PYYX ▲ +14.13% at T+1d
NEUTRAL call ✓ call won +14.13% · α vs SPY +16.73% · entry $2.76 → $3.15
Next anchor: T+5d due yesterday
Currently $3.50 · +26.81% from $2.76 entry
Entry anchored
Jun 4, 2026
via day open
T+1d
+14.13%
call +14.13% · α +16.73%
$3.15
settled 8d ago
T+5d
call — · α —
due yesterday
T+20d
call — · α —
in 20d
T+60d
call — · α —
in 3mo

Price Chart

Loading chart...

Executive Summary

Pyxus International reported strong Q4 FY2026 results with revenue up 35.2% YoY to $678.2M, driven by higher leaf sales volumes from Africa and North America. Full-year adjusted EBITDA reached a record $226.7M, and the leverage ratio improved to 3.52x, a multi-year low. However, FY2027 guidance of $2.3B-$2.5B in sales implies a potential decline from FY2026's $2.413B, and the company noted the global tobacco market has shifted to oversupply.

Key Financial Metrics

Guidance
$2.3B-$2.5B
maintained
Free Cash Flow
-$29.8M
Gross Margin
14.4%

Actionable Insight

The strong Q4 beat and record adjusted EBITDA are positive, but the FY2027 guidance midpoint implies flat-to-slightly-lower revenue and EBITDA vs FY2026, and the oversupply environment may pressure margins. Monitor the Q1 FY2027 earnings call for early shipment trends and any guidance revision.

Key Facts

  • Q4 FY2026 revenue $678.2M, up 35.2% YoY from $501.7M
  • Full-year FY2026 revenue $2,413.0M, down 2.8% YoY from $2,481.3M
  • Full-year FY2026 net income $14.6M vs $15.2M in FY2025
  • Full-year adjusted EBITDA record $226.7M, up from $208.4M in FY2025
  • Leverage ratio improved to 3.52x from 3.70x at FY2025 year-end
  • FY2027 guidance: sales $2.3B-$2.5B, adjusted EBITDA $210M-$240M
  • Global tobacco market has shifted to oversupply; uncommitted inventory at ~9% of processed inventory
  • No outstanding borrowings on $150M ABL at fiscal year-end

Financial Impact

Q4 revenue beat consensus by $176.5M YoY; full-year revenue declined 2.8% YoY; FY2027 guidance midpoint of $2.4B is roughly flat to FY2026 actual of $2.413B

revenuenet incomeadjusted EBITDAleverage ratioinventory

Risk Factors

  • Global tobacco oversupply may pressure pricing and margins in FY2027
  • FY2027 guidance midpoint of $2.4B revenue is essentially flat vs FY2026 actual of $2.413B
  • Higher uncommitted inventory (9% vs 3.6% prior) signals potential price risk
  • Net debt of $798.6M remains elevated despite leverage improvement

Market Snapshot

Exchange
OTC
Sector
Wholesale-Farm Product Raw Materials

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0000939930-26-000018
Document: pyx-20260604.htm0000939930-26-000018
Document: 0000939930-26-000018-index-headers.html0000939930-26-000018
Document: 0000939930-26-000018-index.html0000939930-26-000018
Document: 0000939930-26-000018.txt0000939930-26-000018
8-K Data (Synthetic)0000939930-26-000018

US Market Status

Market Closed — Opens Mon (52h 24m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access